CME Group Inc. (NASDAQ:CME) Shares Sold by Qsemble Capital Management LP

Qsemble Capital Management LP decreased its stake in CME Group Inc. (NASDAQ:CME) by 62.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,357 shares of the financial services provider’s stock after selling 13,839 shares during the period. Qsemble Capital Management LP’s holdings in CME Group were worth $1,844,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Bank of Montreal Can grew its holdings in CME Group by 41.8% in the third quarter. Bank of Montreal Can now owns 1,028,090 shares of the financial services provider’s stock valued at $224,432,000 after purchasing an additional 303,169 shares during the last quarter. Truvestments Capital LLC acquired a new stake in CME Group in the 3rd quarter valued at about $26,000. Independent Advisor Alliance increased its holdings in CME Group by 2.5% during the 3rd quarter. Independent Advisor Alliance now owns 7,135 shares of the financial services provider’s stock valued at $1,574,000 after acquiring an additional 175 shares in the last quarter. Daiwa Securities Group Inc. raised its position in CME Group by 37.8% during the third quarter. Daiwa Securities Group Inc. now owns 54,120 shares of the financial services provider’s stock worth $11,942,000 after acquiring an additional 14,845 shares during the last quarter. Finally, Summit Trail Advisors LLC lifted its holdings in shares of CME Group by 9.7% in the third quarter. Summit Trail Advisors LLC now owns 3,608 shares of the financial services provider’s stock valued at $796,000 after purchasing an additional 319 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of NASDAQ:CME opened at $229.37 on Tuesday. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $230.74. The business has a 50-day moving average of $223.86 and a two-hundred day moving average of $211.19. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market capitalization of $82.66 billion, a PE ratio of 24.12, a P/E/G ratio of 5.28 and a beta of 0.55.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same period last year, the company posted $2.25 earnings per share. The firm’s revenue was up 18.4% compared to the same quarter last year. As a group, research analysts forecast that CME Group Inc. will post 10.22 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be given a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.01%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s dividend payout ratio (DPR) is presently 48.37%.

Insiders Place Their Bets

In other CME Group news, Director Martin J. Gepsman sold 400 shares of the business’s stock in a transaction on Monday, November 4th. The shares were sold at an average price of $222.92, for a total value of $89,168.00. Following the transaction, the director now owns 25,067 shares in the company, valued at $5,587,935.64. The trade was a 1.57 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Timothy Francis Mccourt sold 1,374 shares of the firm’s stock in a transaction dated Monday, October 28th. The shares were sold at an average price of $227.12, for a total value of $312,062.88. Following the sale, the insider now owns 7,275 shares of the company’s stock, valued at $1,652,298. This represents a 15.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 15,621 shares of company stock worth $3,441,063 in the last 90 days. 0.30% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the stock. Morgan Stanley raised their price objective on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 17th. The Goldman Sachs Group boosted their price target on CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a report on Thursday, October 3rd. TD Cowen started coverage on CME Group in a research report on Thursday, September 26th. They set a “hold” rating and a $221.00 price objective for the company. Redburn Atlantic lowered shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price on the stock. in a report on Tuesday, October 8th. Finally, Bank of America lifted their price target on shares of CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a report on Thursday, October 3rd. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $224.47.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.